TENDER AND SUPPORT AGREEMENTTender and Support Agreement • January 7th, 2019 • Loxo Oncology, Inc. • Pharmaceutical preparations • Delaware
This TENDER AND SUPPORT AGREEMENT (this “Agreement”), dated as of January 5, 2019, is entered into by and among Eli Lilly and Company, an Indiana corporation (“Parent”), Bowfin Acquisition Corporation, a Delaware corporation and a direct wholly owned subsidiary of Parent (“Merger Sub”), and each of the entities set forth on Schedule A hereto (each, a “Stockholder” and collectively, the “Stockholders”). All terms used but not otherwise defined in this Agreement shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).
AGREEMENT AND PLAN OF MERGER DATED AS OF JANUARY 5, 2019, AMONG ELI LILLY AND COMPANY, BOWFIN ACQUISITION CORPORATION AND LOXO ONCOLOGY, INC.Merger Agreement • January 7th, 2019 • Loxo Oncology, Inc. • Pharmaceutical preparations • Delaware
AGREEMENT AND PLAN OF MERGER dated as of January 5, 2019 (this “Agreement”), among Eli Lilly and Company, an Indiana corporation (“Parent”), Bowfin Acquisition Corporation, a Delaware corporation (“Merger Sub”) and a wholly owned subsidiary of Parent, and Loxo Oncology, Inc., a Delaware corporation (the “Company”).
